Dr. David Sinclair: Difference between revisions
Line 2: | Line 2: | ||
== Substances Taken by David A. Sinclair == | == Substances Taken by David A. Sinclair == | ||
=== Current === | |||
{| class="wikitable" | {| class="wikitable" | ||
|+ | |+ | ||
Line 56: | Line 57: | ||
| | | | ||
|} | |} | ||
=== Previously === | |||
{| class="wikitable" | {| class="wikitable" | ||
|+ | |+ | ||
! | ! | ||
!NMN | !{{VerticalText|NMN}} | ||
!Reseratrol | !Reseratrol | ||
!Metformin | !Metformin |
Revision as of 19:31, 9 September 2023
David Andrew Sinclair AO (born June 26, 1969) is an Australian-American biologist and academic known for his research on aging and epigenetics. Sinclair is a professor of genetics at Harvard Medical School and is the co-director of its Paul F. Glenn Center for Biology of Aging Research. He is the president of the non-profit Academy for Health & Lifespan Research and an officer of the Order of Australia (AO).
Substances Taken by David A. Sinclair
Current
Substance | Dose | When |
---|---|---|
Nicotinamid Mononukleotid (NMN) | 1000 mg | Morning |
Resveratrol | 1000 mg | Morning |
Metformin | 800 mg | Evening (not when he making excercise and muscles are growing) |
Spermidine | 1000 mg | Morning |
Quercetin | 500 mg | Morning |
Fisetin | 500 mg | Morning |
Vitamin D3 | 4,000 to 5,000 IUs | |
Vitamin K3 | 180 to 360 mcg | |
Low-Dose Aspirin | 83 mg | |
Trimethylglycine (TMG) | 500 - 1000 mg | |
Alpha Lipoic Acid (ALA) | Recent status unknown | |
Coenzyme Q10 (coQ10) | Recent status unknown |
Previously
NMN | Reseratrol | Metformin | |
---|---|---|---|